Long-term follow-up study for epilepsy monitoring implant
Part of Brain & nervous system clinical trials.
This study follows people who previously enrolled in the DETECT study and had a Minder device implanted to monitor brain activity. The goal is to see how the device performs over a longer period of time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were already part of the DETECT study and received the Minder implant.
- You finished the DETECT study — either because the device detected something or you completed 6 months of follow-up.
- You still have the Minder device implanted.
- You still meet the original DETECT study's requirements.
- You do not need any treatments or tests that are not safe with the Minder System, such as an MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device to help diagnose epilepsy in people whose previous EEG brain monitoring did not give clear answers. If you have drug-resistant epilepsy with at least one seizure a month on average, this study may help find better treatment options.
This study is testing a wearable EEG device that you can use at home for up to 30 days. It records brain activity to help doctors better understand your seizures. The goal is to see if this longer monitoring can capture more seizure events than standard short-term EEG tests.
This study tests a wearable ear device that may help detect seizures during your stay in the Epilepsy Monitoring Unit. It aims to see if the device can work alongside standard monitoring to improve seizure detection.
This study tests a wearable device that records seizure-related information to understand how epilepsy affects daily life and safety. It may help your care team better track seizures in real-world settings and understand quality-of-life changes.
This study tests a new ear-worn sensor to monitor brain activity. It will see if the device is safe and easy to use for recording seizures. Healthy volunteers and people with suspected seizures are both needed.
This study tests how well a specific brain-recording device works during a procedure used to map seizure origins in people with drug-resistant, disabling focal epilepsy. It may help doctors plan treatment by improving how well they can localize the seizure focus before possible surgery.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.